Company Intelligence
Serinus Biosciences
Serinus Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized Combinations therapy by rational design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- New York City, United States
- Website
- www.serinus.bio
- Founded
- 2022
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Serinus Biosciences is a Healthcare AI company based in New York City, United States, founded in 2022.
Serinus Biosciences develops combinations therapy by rational design.
What it builds
Combinations therapy by rational design
Why It Matters
Serinus Biosciences provides enterprise-grade artificial intelligence solutions, delivering specialized Combinations therapy by rational design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Serinus Biosciences
Explore Serinus Biosciences by Serinus Biosciences. Verified AI product intelligence covering core capabilities, Enterprise Software use cases, technical…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Serinus Biosciences
Industry
Products
Capabilities
- Combinations therapy by rational design
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Serinus Biosciences do?
Serinus Biosciences specializes in artificial intelligence, developing Combinations therapy by rational design to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Serinus Biosciences based and when was it founded?
Serinus Biosciences is based in United States and was founded in 2022.
What are the main products offered by Serinus Biosciences?
The flagship platform from Serinus Biosciences is Combinations therapy by rational design, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Serinus Biosciences?
Serinus Biosciences primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.